Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
13.81
-0.03 (-0.22%)
Mar 9, 2026, 2:21 PM EDT - Market open
Oscar Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Premiums & Annuity Revenue | 11,470 | 8,971 | 5,686 | 3,871 | 1,886 | Upgrade
|
| Total Interest & Dividend Income | 202.94 | 185.73 | 155.45 | 27.59 | 2.3 | Upgrade
|
| Other Revenue | 28.59 | 20.58 | 21.35 | 64.93 | 5.39 | Upgrade
|
| Total Revenue | 11,701 | 9,178 | 5,863 | 3,964 | 1,894 | Upgrade
|
| Revenue Growth (YoY) | 27.50% | 56.54% | 47.92% | 109.27% | 384.43% | Upgrade
|
| Policy Benefits | 10,019 | 7,333 | 4,642 | 3,281 | 1,624 | Upgrade
|
| Depreciation & Amortization | 28.89 | 32.15 | 30.69 | 15.28 | - | Upgrade
|
| Selling, General & Administrative | 2,050 | 1,756 | 1,426 | 1,257 | 360.16 | Upgrade
|
| Other Operating Expenses | - | - | - | - | 368.07 | Upgrade
|
| Total Operating Expenses | 12,098 | 9,120 | 6,098 | 4,554 | 2,439 | Upgrade
|
| Operating Income | -396.36 | 57.27 | -235.62 | -589.87 | -544.48 | Upgrade
|
| Interest Expense | -17.6 | -23.73 | -24.6 | -22.62 | -4.72 | Upgrade
|
| Other Non Operating Income (Expenses) | -23.34 | -0.11 | -7.08 | 2.42 | -1.2 | Upgrade
|
| EBT Excluding Unusual Items | -437.3 | 33.43 | -267.3 | -610.08 | -550.4 | Upgrade
|
| Other Unusual Items | - | - | - | - | -20.18 | Upgrade
|
| Pretax Income | -437.3 | 33.43 | -267.3 | -610.08 | -570.58 | Upgrade
|
| Income Tax Expense | 5.61 | 7.31 | 3.29 | -0.52 | 0.85 | Upgrade
|
| Earnings From Continuing Ops. | -442.9 | 26.12 | -270.59 | -609.55 | -571.43 | Upgrade
|
| Minority Interest in Earnings | -0.25 | -0.69 | -0.13 | 3.28 | -1.18 | Upgrade
|
| Net Income | -443.15 | 25.43 | -270.73 | -606.28 | -572.61 | Upgrade
|
| Net Income to Common | -443.15 | 25.43 | -270.73 | -606.28 | -572.61 | Upgrade
|
| Shares Outstanding (Basic) | 262 | 240 | 222 | 212 | 179 | Upgrade
|
| Shares Outstanding (Diluted) | 262 | 266 | 222 | 212 | 179 | Upgrade
|
| Shares Change (YoY) | -1.30% | 19.94% | 4.32% | 18.72% | 511.57% | Upgrade
|
| EPS (Basic) | -1.69 | 0.11 | -1.22 | -2.85 | -3.20 | Upgrade
|
| EPS (Diluted) | -1.69 | 0.10 | -1.22 | -2.85 | -3.20 | Upgrade
|
| Free Cash Flow | 1,058 | 950.3 | -297.74 | 351.34 | -207.63 | Upgrade
|
| Free Cash Flow Per Share | 4.03 | 3.58 | -1.34 | 1.65 | -1.16 | Upgrade
|
| Operating Margin | -3.39% | 0.62% | -4.02% | -14.88% | -28.75% | Upgrade
|
| Profit Margin | -3.79% | 0.28% | -4.62% | -15.30% | -30.23% | Upgrade
|
| Free Cash Flow Margin | 9.05% | 10.36% | -5.08% | 8.86% | -10.96% | Upgrade
|
| EBITDA | -367.47 | 89.41 | -204.92 | -574.58 | -529.88 | Upgrade
|
| EBITDA Margin | -3.14% | 0.97% | -3.50% | -14.50% | -27.98% | Upgrade
|
| D&A For EBITDA | 28.89 | 32.15 | 30.69 | 15.28 | 14.61 | Upgrade
|
| EBIT | -396.36 | 57.27 | -235.62 | -589.87 | -544.48 | Upgrade
|
| EBIT Margin | -3.39% | 0.62% | -4.02% | -14.88% | -28.75% | Upgrade
|
| Effective Tax Rate | - | 21.85% | - | - | - | Upgrade
|
| Revenue as Reported | 11,701 | 9,178 | 5,863 | 3,964 | - | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.